Debt-to-equity of INTERPACE BIOSCIENCES, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
INTERPACE BIOSCIENCES, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • INTERPACE BIOSCIENCES, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -1345%, a 3517% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

INTERPACE BIOSCIENCES, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -1345% -1308% -3517% 30 Sep 2025
Q2 2025 -117% -75% -179% 30 Jun 2025
Q1 2025 -65% -21% -47% 31 Mar 2025
Q4 2024 -46% +0.24% +0.52% 31 Dec 2024
Q3 2024 -37% +13% +27% 30 Sep 2024
Q2 2024 -42% +7.8% +16% 30 Jun 2024
Q1 2024 -44% +12% +21% 31 Mar 2024
Q4 2023 -47% +17% +27% 31 Dec 2023
Q3 2023 -51% +20% +28% 30 Sep 2023
Q2 2023 -50% +31% +39% 30 Jun 2023
Q1 2023 -56% +28% +33% 31 Mar 2023
Q4 2022 -64% +22% +26% 31 Dec 2022
Q3 2022 -70% +20% +22% 30 Sep 2022
Q2 2022 -81% +17% +17% 30 Jun 2022
Q1 2022 -84% +31% +27% 31 Mar 2022
Q4 2021 -86% +54% +39% 31 Dec 2021
Q3 2021 -90% +118% +57% 30 Sep 2021
Q2 2021 -98% +386% +80% 30 Jun 2021
Q1 2021 -115% -2925% -104% 31 Mar 2021
Q4 2020 -141% -459% -144% 31 Dec 2020
Q3 2020 -209% -381% -221% 30 Sep 2020
Q2 2020 -483% -586% -572% 30 Jun 2020
Q1 2020 2811% +2729% +3318% 31 Mar 2020
Q4 2019 318% +247% +349% 31 Dec 2019
Q3 2019 172% +110% +176% 30 Sep 2019
Q2 2019 102% +40% +64% 30 Jun 2019
Q1 2019 82% +13% +19% 31 Mar 2019
Q4 2018 71% -26% -27% 31 Dec 2018
Q3 2018 63% -180% -74% 30 Sep 2018
Q2 2018 62% -1023% -94% 30 Jun 2018
Q1 2018 69% +2513% 31 Mar 2018
Q4 2017 97% +2026% 31 Dec 2017
Q3 2017 242% -1572% -87% 30 Sep 2017
Q2 2017 1085% -117% -9.7% 30 Jun 2017
Q1 2017 -2444% -3547% -322% 31 Mar 2017
Q4 2016 -1929% -2852% -309% 31 Dec 2016
Q3 2016 1815% +990% +120% 30 Sep 2016
Q2 2016 1203% +725% +152% 30 Jun 2016
Q1 2016 1103% +813% +281% 31 Mar 2016
Q4 2015 923% +736% +394% 31 Dec 2015
Q3 2015 825% +709% +611% 30 Sep 2015
Q2 2015 477% +371% +347% 30 Jun 2015
Q1 2015 290% +183% +170% 31 Mar 2015
Q4 2014 187% +77% +70% 31 Dec 2014
Q3 2014 116% +4.4% +3.9% 30 Sep 2014
Q2 2014 107% +4.6% +4.5% 30 Jun 2014
Q1 2014 107% +14% +15% 31 Mar 2014
Q4 2013 110% +24% +28% 31 Dec 2013
Q3 2013 112% +30% +36% 30 Sep 2013
Q2 2013 102% +20% +25% 30 Jun 2013
Q1 2013 93% +14% +17% 31 Mar 2013
Q4 2012 86% 31 Dec 2012
Q3 2012 82% 30 Sep 2012
Q2 2012 82% 30 Jun 2012
Q1 2012 80% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.